Sign in

CIK 0001880438

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

AN2 Therapeutics, Inc.

Sign in to watch
Ticker
ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
820606654
Phone
+1 650-331-9090
Business address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
Open-market buys, last 90 days
$11,602
in 1 filing
Open-market sales, last 90 days
$117,428
in 4 filings, $104K under 10b5-1 plans

Net −$105,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-29 Aziz Kabeer Director Purchase +166,666 $15.00 $2.5M 2,210,735
2022-03-29 Aziz Kabeer Director Conversion · Series A Convertible Preferred Stock −1,651,636 0
2022-03-29 Aziz Kabeer Director Conversion · Series A Convertible Preferred Stock −312,415 0
2022-03-29 Aziz Kabeer Director Conversion · Series B Convertible Preferred Stock −392,433 0
2022-03-29 Aziz Kabeer Director Conversion · Series B Convertible Preferred Stock −74,230 0

Page 20 of 20 · 385 trades